Table 6.
Controls (n = 20) | Patients (n = 15) | p | |
---|---|---|---|
LV-EF (%) | 65 ± 4 | 68 ± 7 | 0.24 |
LV-EDV (ml) | 109 ± 27 | 118 ± 28 | 0.57 |
LV-ESV (ml) | 39 ± 13 | 39 ± 14 | 0.91 |
LV-SV | 71 ± 15 | 80 ± 20 | 0.19 |
LV-EDD | 45 ± 5 | 47 ± 4 | 0.36 |
LA (cm2) | 20 ± 3 | 20 ± 3 | 0.71 |
IVS (mm) | 10 ± 2 | 11 ± 2 | 0.11 |
PA (mm) | 24 ± 4 | 24 ± 4 | 0.78 |
LV mass (g) | 85 ± 20 | 92 ± 25 | 0.57 |
LGE per patient | - | 7 (47%) | |
epicardial | - | 3 (20%) | |
intramural | - | 4 (27%) | |
transmural | - | - | |
subendocardial | - | - | |
% LV mass | - | 6.3 ± 4 | |
Native T1 (ms) | 952 (923–960) | 1002 (972–1023) | <0.001 |
Post-contrast T1 (ms) | 524 (500–529) | 490 (477–551) | 0.16 |
ECV (%) | 24.5 (23–25) | 27 (26–28) | <0.001 |
T2 (ms) | 49 (48–51) | 53 (51–54) | <0.001 |
All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume